Visiox - Crunchbase Company Profile & Funding

Q: Where is Visiox's headquarters?

Visiox is located in Tarrytown, New York, United States.

Q: When was the last funding round for Visiox?

Visiox closed its last funding round on obfuscated from a Seed round.

Overview

Visiox

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Visiox

CB Rank

82230

Visiox biopharmaceutical company focused on the development and commercialization to address highly prevalent diseases.

Acquired by

Ocuvex Therapeutics

Founded

obfuscation

Private

Seed

Tarrytown, New York, United States

1-10

www.visioxpharma.com/

Biopharma

Biotechnology

Health Care

Funding Rounds

Seed

OBF

obfuscation

Key People

Sanjay Malieckal: Vice President of Sales & Marketing
Cynthia Matossian: Chief Medical Officer

Details

Legal Name

Visiox Pharma, LLC

Operating Status

Closed

Company Type

For Profit

Founders

Zachary Rome

About the Company

Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options.

Phone Number

9149872876

Predictions & Insights

Products & Services

Omlonti® (omidenepag isopropyl ophthalmic solution) 0.002%

An EP2 receptor agonist ophthalmic solution for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

PDP-716

A once-daily brimonidine formulation for treating ocular hypertension and open-angle glaucoma using TearAct™ fine resin technology.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - Visiox	—	obfuscated obfuscation	—	Seed